Salofalk suppository (mesalazine rectal suppository)
/ Dr Falk
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 25, 2016
Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.
(PubMed)
-
Can J Gastroenterol Hepatol
- "Treatment escalation was common, and total costs of therapy were higher, in patients who initiated treatment with oral 5-ASA. Further study is necessary to assess the significance of these observations."
Journal • Biosimilar • Crohn's disease • Immunology • Inflammatory Bowel Disease
February 13, 2020
BRIEF-Cadila Healthcare says zydus gets final approval from FDA for mesalamine suppositories
(Reuters)
- "Cadila Healthcare LTD says Zydus receives final approval from USFDA for mesalamine suppositories for rectal use, 1000."
sBLA
November 02, 2019
DHSC supply alerts for Delmosart tablets, Salofalk suppositories, and Jext auto-injectors
(Pharmacy Business)
- "The Department of Health and Social Care (DHSC)...issued multiple medicine supply notifications regarding the shortages of...Salofalk suppositories, and Jext adrenaline auto-injectors...Salofalk (mesalazine) 500mg suppositories are out of stock and 1g suppositories will be out of stock from late November. Both stocks are expected to be back by December mid-week. In case of insufficient supplies, prescribers are asked to switch to Pentasa 1g suppositories which remain available during this period."
Commercial
1 to 3
Of
3
Go to page
1